Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03190161 · ClinicalTrials.gov registry record · NA
Music to Reduce Use of Smoking in Patients With Schizophrenia
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03190161 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 2 participants.
The verdict
NCT03190161, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to explore the impact of self-selected music listening which targets disrupting the reward process maintaining smoking and additionally attenuating the reward processing deficits associated with schizophrenia. Five participants with schizophrenia/schizoaffective disorder who smoke/nicotine will participate in an individual session of self-selected music listening for a half an hour.
Interventions
- BEHAVIORAL Music session
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-03-09 |
| Est. Completion | 2018-09-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03190161
The ClinicalTrials.gov registry entry for NCT03190161 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Music session is the first listed.
NCT03190161 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03190161 about?
NCT03190161 is a clinical study titled "Music to Reduce Use of Smoking in Patients With Schizophrenia". The purpose of this study is to explore the impact of self-selected music listening which targets disrupting the reward process maintaining smoking and additionally attenuating the reward processing deficits associated with schizophrenia. Five participants with schizophrenia/schizoaffective disorder...
What is the current status of trial NCT03190161?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2017-03-09. Estimated completion is 2018-09-17.
What interventions are being tested in trial NCT03190161?
The interventions under investigation include: Music session (BEHAVIORAL).
Who is sponsoring clinical trial NCT03190161?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.